Unrequited love drove a 57-year-old man to an AI. Delusions of grandeur followed.

Google reported the first confirmed AI-assisted zero-day exploit, raising new concerns about logic flaws, supply chain risk, and containment. AI-assisted hacking has crossed from theory into a ...

It’s July 20, 1969. Neil Armstrong and Buzz Aldrin are about to land on the moon. They will be the first humans to set foot on Earth’s only natural satellite. Suddenly, the onboard computer flashes: ...

There was a time when the idea of Magic: The Gathering crossing over with other franchises felt impossible. Magic just didn’t do that. When The Walking Dead showed up as a mechanically unique Secret ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $2.94, moving -6.67% from the previous trading session. This change lagged the S&P 500's daily loss of 1.67%. At the same time, ...

“A state of emergency may create breathing room. What matters is what the State does with that time.” Last week I argued that while a state of emergency may temporarily suppress crime, it cannot ...

So, you want to learn Python, huh? It’s a pretty popular language these days, used for all sorts of things like making websites, crunching data, and even AI. The good news is, you don’t need to spend ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

This was largely due to news from a rival clincal-stage biotech. Late on Friday, U.K.-based Biodexa announced it had launched a phase 3 clinical trial of its eRapa, an investigational drug that ...